AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,623,843 | -12.6% | 267,630 | 0.0% | 1.46% | +3.0% |
Q2 2023 | $7,579,282 | +23.3% | 267,630 | 0.0% | 1.42% | +18.4% |
Q1 2023 | $6,147,461 | -18.2% | 267,630 | 0.0% | 1.20% | -31.0% |
Q4 2022 | $7,515,050 | -19.4% | 267,630 | -18.8% | 1.73% | -19.0% |
Q3 2022 | $9,324,000 | -27.0% | 329,713 | -42.8% | 2.14% | -28.2% |
Q2 2022 | $12,779,000 | +1.8% | 576,413 | +33.6% | 2.98% | -3.7% |
Q1 2022 | $12,558,000 | -11.4% | 431,413 | 0.0% | 3.09% | -10.4% |
Q4 2021 | $14,181,000 | +30.5% | 431,413 | +83.2% | 3.46% | +0.2% |
Q3 2021 | $10,869,000 | -16.3% | 235,513 | 0.0% | 3.45% | -22.6% |
Q2 2021 | $12,979,000 | -29.1% | 235,513 | -33.6% | 4.45% | -38.0% |
Q1 2021 | $18,314,000 | +506.4% | 354,650 | +408.8% | 7.19% | +272.0% |
Q4 2020 | $3,020,000 | – | 69,700 | – | 1.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |